Parasitic Infections in HIV-Infected Patients

  • Authors: José M. Miró, MD, PhD; Miriam J. Álvarez-Martínez, MD, PhD (More Info)
  • Editors in Chief: Joseph J. Eron, Jr., MD; Daniel R. Kuritzkes, MD
  • Last Reviewed: 10/20/21 (What's New)

Summary

  • Secondary prophylaxis or chronic maintenance therapy in patients with HIV and latent Chagas disease may not be needed, particularly if ART is used[CDC OI; GESIDA OI]
  • Some clinicians suggest maintaining the same daily dose used with primary prophylaxis given 3 times per week
  • Prophylaxis should be stopped in patients receiving ART with CD4+ cell counts > 200 cells/mm3 and undetectable HIV-1 RNA

Action required